Loading clinical trials...
Loading clinical trials...
Pilot Study Evaluating the Efficacy, Tolerance and Safety of VITAL AF (Semi Elemental, High Protein, High Omega 3 Fat Enteral Formula) Versus Osmolite 1.2 (High Protein Enteral Formula) in Multiple ICU Settings (Medical, Surgical, Cardiothoracic)
Conditions
Interventions
VITAL AF
Osmolite 1.2
Locations
1
United States
NewYork-Presbyterian Hospital at Columbia University Medical Center
New York, New York, United States
Start Date
October 1, 2011
Primary Completion Date
November 1, 2014
Completion Date
November 1, 2014
Last Updated
June 23, 2015
NCT06667999
NCT07298720
NCT07478380
NCT04955210
NCT04850456
NCT07128446
Lead Sponsor
Columbia University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions